The Publisher wishes to call attention to an error that occurred in the Fifth Edition of the American Society for Apheresis (ASFA) Special Issue on Clinical Applications of Therapeutic Apheresis. Dr. Beth H. Shaz was co-Guest Editor of the 5 th Special Issue but was not identified as having made th
Clinical applications of therapeutic apheresis
β Scribed by Rasheed A. Balogun; Andre Kaplan; David M. Ward; Chidi Okafor; Ted M. Burns; A. Sergio Torloni; B. Gail Macik; Emaad M. Abdel-Rahman
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 159 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0733-2459
No coin nor oath required. For personal study only.
β¦ Synopsis
Although the vast majority of patients with IgA nephropathy run a benign renal course, IgA nephropathy is sometimes associated with RPGN. Removal of circulating IgA-containing immune complexes may prevent worsening of renal function in such patients with IgA
π SIMILAR VOLUMES
## Abstract The American Society for Apheresis (ASFA) Apheresis Applications Committee is responsible for a review and categorization of indications for therapeutic apheresis. The results of the review process were previously published in 1986, 1993, and 2000 as the ASFA Special Issues. The ASFA ca
A "snapshot" survey of physician coverage for evaluation and supervision of therapeutic apheresis procedures shows significant variation in current clinical practice between 39 blood center-and 41 non-blood center-based programs. Whereas 56% of blood center-based programs usually require physician's
The development and future trend of therapeutic apheresis in Europe was analyzed. Demographic data on its distribution were collected with the help of the marketing departments of four commercial companies. The differences in application in European countries were examined and compared with North Am